Janney Montgomery Scott’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.21M | Buy |
236,834
+33,951
| +17% | +$306K | 0.01% | 1220 |
|
|
2025
Q4 | $1.82M | Buy |
202,883
+19,182
| +10% | +$181K | ﹤0.01% | 1384 |
|
|
2025
Q3 | $1.75M | Sell |
183,701
-72,963
| -28% | -$732K | ﹤0.01% | 1390 |
|
|
2025
Q2 | $2.26M | Sell |
256,664
-23,870
| -9% | -$194K | 0.01% | 1151 |
|
|
2025
Q1 | $2.1M | Sell |
280,534
-16,860
| -6% | -$134K | 0.01% | 1139 |
|
|
2024
Q4 | $2.48M | Sell |
297,394
-7,675
| -3% | -$65.5K | 0.01% | 1062 |
|
|
2024
Q3 | $2.12M | Sell |
305,069
-127,755
| -30% | -$867K | 0.01% | 1118 |
|
|
2024
Q2 | $2.12M | Sell |
432,824
-227,345
| -34% | -$1.08M | 0.01% | 1078 |
|
|
2024
Q1 | $3.83M | Sell |
660,169
-23,262
| -3% | -$143K | 0.01% | 856 |
|
|
2023
Q4 | $4.48M | Buy |
683,431
+9,062
| +1% | +$42.4K | 0.01% | 779 |
|
|
2023
Q3 | $3.25M | Buy |
674,369
+151,599
| +29% | +$757K | 0.01% | 836 |
|
|
2023
Q2 | $2.67M | Sell |
522,770
-5,985
| -1% | -$32.3K | 0.01% | 941 |
|
|
2023
Q1 | $2.91M | Buy |
528,755
+34,725
| +7% | +$184K | 0.01% | 825 |
|
|
2022
Q4 | $2.27M | Buy |
494,030
+14,650
| +3% | +$74.4K | 0.01% | 967 |
|
|
2022
Q3 | $2.99M | Buy |
479,380
+160
| +0% | +$906 | 0.01% | 801 |
|
|
2022
Q2 | $2.17M | Buy |
479,220
+129,100
| +37% | +$589K | 0.01% | 897 |
|
|
2022
Q1 | $1.76M | Buy |
350,120
+64,205
| +22% | +$409K | 0.01% | 972 |
|
|
2021
Q4 | $2.49M | Buy |
285,915
+6,475
| +2% | +$57.8K | 0.01% | 867 |
|
|
2021
Q3 | $2.61M | Buy |
279,440
+20,775
| +8% | +$209K | 0.01% | 826 |
|
|
2021
Q2 | $3.32M | Buy |
258,665
+246,365
| +2,003% | +$2.65M | 0.01% | 730 |
|
|
2021
Q1 | $113K | Buy |
+12,300
| New | +$107K | ﹤0.01% | 2120 |
|
|
2019
Q3 | – | Sell |
-841
| Closed | -$24K | – | 2157 |
|
|
2019
Q2 | $24K | Sell |
841
-800
| -49% | -$20.1K | ﹤0.01% | 2031 |
|
|
2019
Q1 | $44K | Buy |
1,641
+88
| +6% | +$3.24K | ﹤0.01% | 1975 |
|
|
2018
Q4 | $44K | Buy |
+1,553
| New | +$62.8K | ﹤0.01% | 1914 |
|
Other funds holding ZVRA
WP
NCM
VCM
ACM
